Correlation of NUCB2/Nesfatin-1 with Cytokine Levels in Primary Open-Angle Glaucoma

References

• Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96(5):614–618. doi:10.1136/bjophthalmol-2011-300539
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Nakazawa C, Matsubara A, et al. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci. 2006;26(49):12633–12641. doi:10.1523/JNEUROSCI.2801-06.2006
   Web of Science ®Google Scholar
• Tezel G, Li LY, Patil RV, Wax MB. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 2001;42(8):1787–1794.
   PubMed Web of Science ®Google Scholar
• Vajaranant TS, Nayak S, Wilensky JT, Joslin CE. Gender and glaucoma: what we know and what we need to know. Curr Opin Ophthalmol. 2010;21(2):91–99. doi:10.1097/ICU.0b013e3283360b7e
   PubMed Web of Science ®Google Scholar
• Oh IS, Shimizu H, Satoh T, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006;443(7112):709–712. doi:10.1038/nature05162
   PubMed Web of Science ®Google Scholar
• Gong JL, Lou XT, Yuan YX, et al. The increased expression of GABA receptors within the arcuate nucleus is associated with high intraocular pressure. Mol Vis. 2018;24:574–586.
   PubMed Web of Science ®Google Scholar
• Ayada C, Toru U, Korkut Y. Nesfatin-1 and its effects on different systems. Hippokratia. 2015;19(1):4–10.
   PubMed Web of Science ®Google Scholar
• Pan W, Hsuchou H, Kastin AJ. Nesfatin-1 crosses the blood-brain barrier without saturation. Peptides. 2007;28(11):2223–2228. doi:10.1016/j.peptides.2007.09.005
   PubMed Web of Science ®Google Scholar
• Price TO, Samson WK, Niehoff ML, Banks WA. Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1. Peptides. 2007;28(12):2372–2381. doi:10.1016/j.peptides.2007.10.008
   PubMed Web of Science ®Google Scholar
• Samuels BC, Hammes NM, Johnson PL, Shekhar A, McKinnon SJ, Allingham RR. Dorsomedial/Perifornical hypothalamic stimulation increases intraocular pressure, intracranial pressure, and the translaminar pressure gradient. Invest Ophthalmol Vis Sci. 2012;53(11):7328–7335. doi:10.1167/iovs.12-10632
   PubMed Web of Science ®Google Scholar
• Guzman-Ruiz M, Saderi N, Cazarez-Marquez F, et al. The suprachiasmatic nucleus changes the daily activity of the arcuate nucleus alpha-MSH neurons in male rats. Endocrinology. 2014;155(2):525–535. doi:10.1210/en.2013-1604
   Web of Science ®Google Scholar
• Ozsavci D, Ersahin M, Sener A, et al. The novel function of nesfatin-1 as an anti-inflammatory and antiapoptotic peptide in subarachnoid hemorrhage-induced oxidative brain damage in rats. Neurosurgery. 2011;68(6):1699–1708; discussion 1708. doi:10.1227/NEU.0b013e318210f258
   Web of Science ®Google Scholar
• Davis BM, Tian K, Pahlitzsch M, et al. Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension. Mitochondrion. 2017;36:114–123. doi:10.1016/j.mito.2017.05.010
   PubMed Web of Science ®Google Scholar
• Chen SD, Wang L, Zhang XL. Neuroprotection in glaucoma: present and future. Chin Med J (Engl). 2013;126(8):1567–1577.
   Web of Science ®Google Scholar
• Tian K, Shibata-Germanos S, Pahlitzsch M, Cordeiro MF. Current perspective of neuroprotection and glaucoma. Clin Ophthalmol. 2015;9:2109–2118. doi:10.2147/OPTH.S80445
   PubMed Web of Science ®Google Scholar
• Soto I, Howell GR. The complex role of neuroinflammation in glaucoma. Cold Spring Harb Perspect Med. 2014;4(8):a017269–a017269. doi:10.1101/cshperspect.a017269
   PubMed Web of Science ®Google Scholar
• Xu H, Chen M, Forrester JV. Para-inflammation in the aging retina. Prog Retin Eye Res. 2009;28(5):348–368. doi:10.1016/j.preteyeres.2009.06.001
   PubMed Web of Science ®Google Scholar
• Zhou X, Li F, Ge J, et al. Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma. Dev Neurobiol. 2007;67(5):603–616. doi:10.1002/dneu.20373
   PubMed Web of Science ®Google Scholar
• Huang P, Qi Y, Xu YS, et al. Serum cytokine alteration is associated with optic neuropathy in human primary open angle glaucoma. J Glaucoma. 2010;19(5):324–330. doi:10.1097/IJG.0b013e3181b4cac7
   PubMed Web of Science ®Google Scholar
• Huang P, Zhang SS, Zhang C. The two sides of cytokine signaling and glaucomatous optic neuropathy. J Ocul Biol Dis Infor. 2009;2(2):78–83. doi:10.1007/s12177-009-9026-6
   Google Scholar
• Huang W, Chen S, Gao X, et al. Inflammation-related cytokines of aqueous humor in acute primary angle-closure eyes. Invest Ophthalmol Vis Sci. 2014;55(2):1088–1094. doi:10.1167/iovs.13-13591
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen S, Liu Y, Huang W, Li X, Zhang X. Inflammatory cytokine profiles in eyes with primary angle-closure glaucoma. Biosci Rep. 2018;38(6). doi:10.1042/BSR20181411
   Web of Science ®Google Scholar
• Wang WH, McNatt LG, Pang IH, et al. Increased expression of serum amyloid A in glaucoma and its effect on intraocular pressure. Invest Ophthalmol Vis Sci. 2008;49(5):1916–1923. doi:10.1167/iovs.07-1104
   Web of Science ®Google Scholar
• Chono I, Miyazaki D, Miyake H, et al. High interleukin-8 level in aqueous humor is associated with poor prognosis in eyes with open angle glaucoma and neovascular glaucoma. Sci Rep. 2018;8(1):14533. doi:10.1038/s41598-018-32725-3
   PubMed Web of Science ®Google Scholar
• Takano Y, Shi D, Shimizu A, et al. Association of Toll-like receptor 4 gene polymorphisms in Japanese subjects with primary open-angle, normal-tension, and exfoliation glaucoma. Am J Ophthalmol. 2012;154(5):825–832 e821. doi:10.1016/j.ajo.2012.03.050
   Web of Science ®Google Scholar
• Wang CY, Shen YC, Wei LC, et al. Polymorphism in the TNF-alpha(−863) locus associated with reduced risk of primary open angle glaucoma. Mol Vis. 2012;18:779–785.
   Web of Science ®Google Scholar
• Wei X, Cho KS, Thee EF, Jager MJ, Chen DF. Neuroinflammation and microglia in glaucoma: time for a paradigm shift. J Neurosci Res. 2019;97(1):70–76. doi:10.1002/jnr.24256
   PubMed Web of Science ®Google Scholar
• Howell GR, Macalinao DG, Sousa GL, et al. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J Clin Invest. 2011;121(4):1429–1444. doi:10.1172/JCI44646
   PubMed Web of Science ®Google Scholar
• Bosco A, Steele MR, Vetter ML. Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol. 2011;519(4):599–620. doi:10.1002/cne.22516
   Web of Science ®Google Scholar
• Bosco A, Inman DM, Steele MR, et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci. 2008;49(4):1437–1446. doi:10.1167/iovs.07-1337
   PubMed Web of Science ®Google Scholar
• Howell GR, Soto I, Zhu X, et al. Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma. J Clin Invest. 2012;122(4):1246–1261. doi:10.1172/JCI61135
   Web of Science ®Google Scholar
• Naganuma F, Bandaru SS, Absi G, Chee MJ, Vetrivelan R. Melanin-concentrating hormone neurons promote rapid eye movement sleep independent of glutamate release. Brain Struct Funct. 2019;224(1):99–110. doi:10.1007/s00429-018-1766-2
   Web of Science ®Google Scholar
• Arabaci Tamer S, Yildirim A, Koroglu MK, Cevik O, Ercan F, Yegen BC. Nesfatin-1 ameliorates testicular injury and supports gonadal function in rats induced with testis torsion. Peptides. 2018;107:1–9. doi:10.1016/j.peptides.2018.07.005
   PubMed Web of Science ®Google Scholar
• Arenas-Ramirez N, Woytschak J, Boyman O. Interleukin-2: biology, design and application. Trends Immunol. 2015;36(12):763–777. doi:10.1016/j.it.2015.10.003
   PubMed Web of Science ®Google Scholar
• Minty A, Chalon P, Derocq JM, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature. 1993;362(6417):248–250. doi:10.1038/362248a0
   Web of Science ®Google Scholar
• Xia QR, Liang J, Cao Y, Shan F, Liu Y, Xu YY. Increased plasma nesfatin-1 levels may be associated with corticosterone, IL-6, and CRP levels in patients with major depressive disorder. Clin Chim Acta. 2018;480:107–111. doi:10.1016/j.cca.2018.02.004
   PubMed Web of Science ®Google Scholar
• Gramlich OW, Ding QJ, Zhu W, Cook A, Anderson MG, Kuehn MH. Adoptive transfer of immune cells from glaucomatous mice provokes retinal ganglion cell loss in recipients. Acta Neuropathol Commun. 2015;3:56. doi:10.1186/s40478-015-0234-y
   PubMed Web of Science ®Google Scholar
• Howell GR, MacNicoll KH, Braine CE, et al. Combinatorial targeting of early pathways profoundly inhibits neurodegeneration in a mouse model of glaucoma. Neurobiol Dis. 2014;71:44–52. doi:10.1016/j.nbd.2014.07.016
   PubMed Web of Science ®Google Scholar
• Qu J, Jakobs TC, Di Giovanni S. The time course of gene expression during reactive gliosis in the optic nerve. PLoS One. 2013;8(6):e67094. doi:10.1371/journal.pone.0067094
   PubMed Web of Science ®Google Scholar
• Levkovitch-Verbin H, Waserzoog Y, Vander S, Makarovsky D, Ilia P. Minocycline mechanism of neuroprotection involves the Bcl-2 gene family in optic nerve transection. Int J Neurosci. 2014;124(10):755–761. doi:10.3109/00207454.2013.878340
   PubMed Web of Science ®Google Scholar
• Levkovitch-Verbin H, Waserzoog Y, Vander S, Makarovsky D, Piven I. Minocycline upregulates pro-survival genes and downregulates pro-apoptotic genes in experimental glaucoma. Graefes Arch Clin Exp Ophthalmol. 2014;252(5):761–772. doi:10.1007/s00417-014-2588-4
   Web of Science ®Google Scholar
• Mac Nair CE, Fernandes KA, Schlamp CL, Libby RT, Nickells RW. Tumor necrosis factor alpha has an early protective effect on retinal ganglion cells after optic nerve crush. J Neuroinflammation. 2014;11:194. doi:10.1186/s12974-014-0194-3
   Web of Science ®Google Scholar
• Cueva Vargas JL, Osswald IK, Unsain N, et al. Soluble tumor necrosis factor alpha promotes retinal ganglion cell death in glaucoma via calcium-permeable AMPA receptor activation. J Neurosci. 2015;35(35):12088–12102. doi:10.1523/JNEUROSCI.1273-15.2015
   Web of Science ®Google Scholar
• Sims SM, Holmgren L, Cathcart HM, Sappington RM. Spatial regulation of interleukin-6 signaling in response to neurodegenerative stressors in the retina. Am J Neurodegener Dis. 2012;1(2):168–179.
   Google Scholar
• Sappington RM, Chan M, Calkins DJ. Interleukin-6 protects retinal ganglion cells from pressure-induced death. Invest Ophthalmol Vis Sci. 2006;47(7):2932–2942. doi:10.1167/iovs.05-1407
   PubMed Web of Science ®Google Scholar
• Tong Y, Zhou YL, Zheng Y, Biswal M, Zhao PQ, Wang ZY. Analyzing cytokines as biomarkers to evaluate severity of glaucoma. Int J Ophthalmol. 2017;10(6):925–930. doi:10.18240/ijo.2017.06.15
   Web of Science ®Google Scholar
• Garweg JG, Zandi S, Pfister IB, Skowronska M, Gerhardt C. Comparison of cytokine profiles in the aqueous humor of eyes with pseudoexfoliation syndrome and glaucoma. PLoS One. 2017;12(8):e0182571. doi:10.1371/journal.pone.0182571
   PubMed Web of Science ®Google Scholar
• Ten Berge JC, Fazil Z, van den Born I, et al. Intraocular cytokine profile and autoimmune reactions in retinitis pigmentosa, age-related macular degeneration, glaucoma and cataract. Acta Ophthalmol. 2019;97(2):185–192. doi:10.1111/aos.13899
   PubMed Web of Science ®Google Scholar
• Schwartz B. Circulatory defects of the optic disk and retina in ocular hypertension and high pressure open-angle glaucoma. Surv Ophthalmol. 1994;38(Suppl):S23–34. doi:10.1016/0039-6257(94)90044-2
   Google Scholar
• Arend O, Remky A, Plange N, Kaup M, Schwartz B. Fluorescein leakage of the optic disc in glaucomatous optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2005;243(7):659–664. doi:10.1007/s00417-004-1092-7
   Web of Science ®Google Scholar
• Easthope SE, Perry CM. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension. Drugs Aging. 2002;19(3):231–248. doi:10.2165/00002512-200219030-00008
   PubMed Web of Science ®Google Scholar